Fred Senatore (FDA, USA)
(Speaker)
- Dr. Kamphaus is trained in molecular genetics and cell biology and skilled in strategic planning and collaborative program development across basic, translational and patient-centric clinical research. Dr. Kamphaus conducted her postdoctoral fellowship at Columbia University. She earned her PhD in Molecular Genetics from The Ohio State University and her Master’s degree in Biotechnology from Madurai Kamaraj University, India.
Dr. Fred Senatore has been a medical officer in the Division of Cardiology and Nephrology at the US Food and Drug Administration since 2012 and has served as Teal Leader/ Lead Physician since January 2020. Prior to his tenure at the FDA, Dr. Senatore served in the pharmaceutical industry with increasing responsibility over a span of 17 years.
Dr Senatore received his BA in Biochemistry and MS in Bioengineering from Columbia University, his PhD in Chemical Engineering from Rutgers University, his MD degree from the Texas Tech University School of Medicine, his Internal Medicine training at the Mayo Clinic, and his Cardiology training at Harvard Medical School / Massachusetts General Hospital. He was a professor of Chemical Engineering at Texas Tech University, specializing in artificial organ technology, biocompatibility, hemodynamics, and modeling/simulation of biological processes.
Dr. Senatore specializes in clinical trial design, ascertainment of substantial evidence of effectiveness, and benefit-risk evaluation.
Beyond Technologies.